Equity Details
Price & Market Data
Price: $64.98
Daily Change: -$0.70 / 1.08%
Daily Range: $62.96 - $67.00
Market Cap: $3,869,749,504
Daily Volume: 1,088,243
Performance Metrics
1 Week: -6.24%
1 Month: 5.33%
3 Months: 96.62%
6 Months: 133.0%
1 Year: 563.1%
YTD: 113.3%
About Oruka Therapeutics, Inc. (ORKA)
Get the latest market data on Oruka Therapeutics, Inc. (ORKA). Price: 64.98, daily change: -$0.70 / 1.08%. Market cap: 3,869,749,504. Comprehensive performance from 3-month to 1-year.
Company Details
Employees: 68
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.